臺灣博碩士論文加值系統

異位性皮膚炎 (Atopic dermatitis，簡稱AD)，是一種慢性、具有不同程度的反覆發作的過敏性皮膚疾病，常見症狀包含發癢、紅腫，以及皮膚龜裂，異位性皮膚炎可能由多種誘因引起，包括過敏原，食物過敏原，塵蟎，天氣變化，溫度變化和壓力。並且在過去的幾十年中，其發病率在全世界範圍內都在增加，因發病過程會造成過度的抓搔，影響睡眠及生活品質，為患者及其家人帶來了嚴重的社會心理負擔。益生菌 (Probiotics)，可改善胃腸道中微生物的平衡，並通過各種機制發揮有益作用，包括降低腸道pH值，減少病原生物的定植和入侵以及改變宿主的免疫反應。許多研究結果顯示，食用益生菌對異位性皮膚炎患者具有改善效果。然市面上益生菌產品琳瑯滿目，多半主打腸胃道保健及免疫調節功能性為訴求。因此本研究針對消費者對於異位性皮膚炎與益生菌產品認知及購買行為作探討，使用Surevycake網路問卷於2021年4月1日至2021年4月15日 其間發放回收。實際回收樣本數為452份，有效問卷數達377份，有效回收率為83%。本研究受測者男女比例約1:1.5，年齡分佈以21-50為主，大專或大學學歷以上，行業以商務職居多，平均月收入5萬元以下，未婚及已婚比例約1:1，受測者與異位性皮膚炎的關係度以無關係居多。有購買益生菌之受測者購買頻率為每月一次，食用頻率以想到才吃居多，平均每次花費以500元以下及1001-1500元，購買劑型以粉劑為大宗，其獲得資訊管道為網路媒體，受測者選擇便利商店、大型連鎖超及及藥局作為主要購買通路。當受測者對於異位性皮膚炎與益生菌產品認知程度越高，則平均購買金額及食用頻率也越高。本研究所得之統計分析結果可作為企業於針對異位性皮膚炎患者為銷售目標族群開發益生菌時需要鎖定之目標族群、鋪貨通路及產品行銷策略作為參考資料，也希望透過本研究之結果讓消費者對於益生菌與異位性皮膚炎有更加了瞭解。

Atopic dermatitis is a chronic, recurring allergic skin disease of varying degrees. Common symptoms include itching, redness, and cracking of the skin. Atopic derma-titis may be caused by a variety of factors, including allergens, food allergens, dust mites, weather changes, temperature changes and stress. And in the past few decades, its incidence has been increasing worldwide. Due to the course of the disease, excessive scratching will be caused, which affects sleep and quality of life, and brings a serious social and psychological burden to patients and their families. Probiotics can improve the balance of microorganisms in the gastrointestinal tract and exert beneficial effects through various mechanisms, including lowering the pH of the intestines, reducing the colonization and invasion of pathogens, and changing the host's immune response. Many studies have shown that the consumption of probiotics can improve patients with atopic dermatitis. However, the most of probiotic products on the market focus on gastrointestinal health and immune regulation functions. Therefore, this study is aimed at consumers' perception and purchase behavior of atopic dermatitis and probiotic products. The research method used the Surevycake online questionnaire distribution and collected from April 1 to 15, 2021. The actual number of samples recovered was 452, the number of valid questionnaires reached 377, and the effective recovery rate was 83%. The ratio of men to women in this study is about 1:1.5, the age distribution is mainly 21-50, college or university degree or above, the industry is mostly business, and the average monthly income is less than NT$50,000, the ratio of unmarried to married is about 1:1, and the relationship degree of atopic dermatitis is mostly unrelated. The test subjects buy probiotics once a month, the frequency of consumption is mostly when they think about it, and the average cost per time is less than NT$500 and NT$1001-1500. The bulk of the dosage form is powder, and the information channel is online media. The test subjects choose convenience stores, supermarkets and pharmacies as their main purchase channels. When the test subjects have higher awareness of atopic dermatitis and probiotic products, their average purchase amount and frequency of consumption are also higher. The statistical analysis results obtained in this study can be used as reference materials for the target audience, distribution channels and product marketing strategies which a company develops probiotics for the sales target group for patients with atopic dermatitis. And also hope that through the results of this research, consumers will have a better understanding of probiotics and atopic dermatitis.

摘要.................................................I
Abstract............................................II
目次................................................III
圖目錄...............................................IV
表目錄................................................V
第一章 緒論...........................................1
第一節 研究背景......................................1
第二節 研究目的......................................1
第三節 研究流程......................................1
第二章 文獻回顧.......................................2
第一節 異位性皮膚炎(Atopic dermatitis)................2
第二節 益生菌(Probiotics).............................4
第三節 台灣健康食品法規................................7
第四節 益生菌食品相關法規..............................8
第五節 益生菌食品市場概況..............................9
第三章 研究方法.......................................10
第一節 研究方法.....................................10
第二節 問卷施測.....................................10
第三節 問卷設計.....................................10
第四節 研究架構.....................................10
第五節 研究變數.....................................11
第六節 研究假設.....................................12
第七節 資料處理及分析方法............................12
第四章 結果與討論.....................................14
第一節 描述性分析...................................14
第二節 信度分析.....................................16
第三節 人口統計變數與益生菌產品消費行為分析............17
第四節 人口統計變數與益生菌產品認知差異分析............18
第五節 異位性皮膚炎與益生菌及其相關產品認知對於消費行為及
產品健康關聯性在意程度之相關性.................19
第五章 結論與建議......................................20
參考文獻..............................................23
附錄1.前測問卷.........................................63
附錄2.正式問...........................................70 

一、中文文獻：

中華穀類食品工業技術研究所。2021。2019國內保健營養食品產值暨產業概況分析。
李林璦。2020。擠進全求十大 臺灣益生菌產業航進新藍海。環球生技月刊。70：94-99。
林志侯。2010。乳酸菌載體表現系統之研究現況與趨勢。農業生技產業季刊。23：29-40。
邱皓政。2002。量化研究與統計分析。五南圖書出版股分有限公司。
食品工業發展研究所。2019。2019食品產業年鑑。
臺灣皮膚科醫學會。2020。異位性皮膚炎診療共識。臺灣皮膚科醫學會出版。
蔡嘉文、鄭隆致、温孟娟、潘豐泉。2017。益生菌保健食品之消費行為意圖研究：以計畫行為理論為理論基礎。寶建醫護與管理雜誌。14(1)：51-78。

二、英文文獻：
Akbari V, Hendijani F. (2016). Effects of probiotic supplementation in patients with type 2 diabetes: Systematic review and meta-analysis. Nutrition Reviews,
74(12):774-784.
Alander M, Satokari R, Korpela R. (1999). Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Applied and Environmental Microbiology, 65:351-4.
Bartlett JG. (1992). Antibiotic‐associated diarrhea. Clinical Infectious Diseases, 15(4): 573-81.
Bennet SM, Ohman L, Simren M. (2015). Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver, 9(3):318-331.
Blaut M. (2002). Relationship of prebiotics and food to intestinal microflora. European Journal of Nutrition, 41:11–16.
Boyle RJ, Robins-Browne RM, Tang ML. (2006). Probiotic use in clinical practice: what are the risks? The American Journal of Clinical Nutrition, 83(6):1256-1447.
Cao YN, Feng LJ, Liu YY. (2018). Effect of Lactobacillus rhamnosus GG supernatant on serotonin transporter expression in rats with post-infectious irritable bowel
syndrome. World J Gastroenterol, 24:338–50.
Celakovská J, Bukač J. (2016). The severity of atopic dematitis evaluated with the SCORAD index and the occurrence of bronchial asthma and rhinitis, and the duration of atopoic dermatitis. Allergy Rhinol Providence, 7(1):8-13.
Cremonini F, Caro SD, Nista EC, Bartolozzi F, Capelli G, Gasbarrini G, Gasbarrini A. (2002). Meta‐analysis: the effect of probiotic administration on antibiotic-associated diarrhea. Alimentary Pharmacology and Therapeutics, 16(8): 1461-1467.
Chi C, Li C, Wu D. (2020). Effects of probiotics on patients with hypertension: a systematic review and meta-analysis.Current Hypertension Reports, 22(5):1-8.
Dong H, Rowland I, Yaqoob P. (2012). Comparative effects of six probiotic strains on immune function in vitro. British Journal of Nutrition, 108(3):459-470.
Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K. (2014). Guidelines of care for the management of atopic dermatitis. Journal of the American Academy of Dermatolog, 71:116-132.
Feldman RJ, Maibach HI. (1967). Regional variation in percutaneous penetration of 14C cortisol in man. J Invst Dermatol, 48: 181-183.
Fenster K, Freeburg B, Hollard C, Wong C, Rønhave Laursen R, & Ouwehand AC. (2019). The Production and Delivery of Probiotics: A Review of a Practical Approach. Microorganisms, 7(3):83.
Finegold SM. (1970). Interaction of antimicrobial therapy and intestinal flora. The American Journal of Clinical Nutrition, 23: 1466-71.
Ghanavati M, Hosseini SA, Alipour M, Ashtari-larky D, Cheraghpour K. (2015). The role of probiotics in the management of cardiovascular disease risk factors. Journal of Clinical Excellence, 4:138-156.
Gibson G, Hutkins R, Sanders ME, et al. (2017). Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nature Reviews Gastroenterology and Hepatology, 14(8):491-502.
Gibson G, Probert H, Loo J, Rastall R, Roberfroid M.(2004). Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics. Nutrition Research Reviews, 17(2): 259-275.
Gibson G, Roberfroid M. (1995). Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics, Journal of Nutrition, 125(6):1401-1412.
Hajar T, Lesham YA, Hanifin JM. (2015). A systematic review of topical corticosteroid withdrawal “steroid addiction” in patients with atopic dermatitis and other dermatoses. Journal of the American Academy of Dermatolog,
72: 541-549.
Hanifin JM, Rajka G. (1980). Diagnostic Features of Atopic Dermatitis. Acta Derm Venereol Suppl, 92: 44-47.
Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME. (2014). Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology and Hepatology, 11 (8): 506-514.
Hoare C, Li Wan Po A, Williams H. (2000). Systematic review of treatments for atopic eczema. Health Technol Assess, 4: 1-191.
Huang R, Ning H, Shen M, Li J, Zhang J, Chen Xiang. (2017). Probiotics for the treatment of atopic dermatitis in children: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Cellular and Infection Microbiology, 7:392.
Isolauri E, Rautava S, Kalliomäki M, Kirjavainen P, Salminen S. (2002). Role of probiotics in food hypersensitivity. Current Opinion in Allergy and Clinical
Immunology, 2:263-71.
Ivory K, Chambers SJ, Pin C, Prieto E, Arqués JL, Nicoletti C. (2008). Oral delivery of Lactobacillus casei Shirota modifies allergen-induced immune responses in allergic rhinitis. Clin Exp Allergy, 38:1282-9.
Kang H, Lee CH, Kim JR, Kwon JY, Seo SG, Han JG, Kim BG, Kim JE, Lee KW. (2015). Chlorella vulgaris attenuates dermatophagoides farinae-Induced atopic dermatitis-like symptoms in NC/Nga mice. International Journal of Molecula Science, 16(9): 21021-21034.
Katoh N, Ohya Y, Ikeda M, Ebihara T, Katayama I, Saeki H, Shimojo N, Tanaka A, Nakahara T, Nagao M, Hide M, Fujita Y, Fujisawa T, Futamura M, Masuda K, Murota H, Yamamoto‐Hanada K. (2019). Clinical practice guidelines for the management of atopic dermatitis 2018. The Journal of Dermatology, 46(12):1053-1101.
Kato-Kataoka A, Nishida K, Takada M. (2016). Fermented milk containing Lactobacillus casei strain Shirota preserves the diversity of the gut microbiota and relieves abdominal dysfunction in healthy medical students exposed to academic stress. Applied and Environmental Microbiology, 82:3649-58.
Komine Y, Watanabe M, Soutome T, Uchino T, Dobashi M, Harata G, Miyazawa K, He F, Rautava S, Salminen S. (2018). Maternal consumption of Lactobacillus GG during pregnancy preventsInfant eczema at 1 year of age. Journal of Allergy and Therapy, 9(2):277-281. 
Kuo IH, Yoshida T, De Benedetto A, Beck LA. (2013). The cutaneous innate immune response in patients with atopic dermatitis. Jouranl of Allergy and Clinical Immunology, 131(2):266-278.
Lewis-Mikhael AM, Davoodvandi A, Jafarnejad S. (2020). Effect of Lactobacillus plantarum containing probiotics on blood pressure: A systematic review and meta-analysis. Pharmacological Research, 153:104663.
Liang S, Wang T, Hu X, (2015). Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by
chronic restraint stress. Neuroscience , 310:561–77.
Lin CH, Lin CC, Shibu MA. (2014). Oral Lactobacillus reuteri GMN-32 treatment reduces blood glucose concentrations and promotes cardiac function in rats with streptozotocin-induced diabetes mellitus. British Journal of Nutrition, 111:598-605.
Miller LE, Lehtoranta L, Lehtinenb MJ. (2019). Short-term probiotic supplementation enhances cellular immune function in healthy elderly: Systematic review and meta-analysis of controlled studies. Nutrition Research, 64:1-8.
Navarro-López V, Ramírez-Boscá A, Ramón-Vidal D, Ruzafa-Costas B, Genovés-Martínez S, Chenoll-Cuadros E, Carrión-Gutiérrez M, Horga de la Parte J, Prieto-Merino D, Codoñer-Cortés M. (2018). Effect of oral administration of a mixture of probiotic strains on SCORAD index and use of topical steroids in young patients with moderate atopic dermatitis: A randomized clinical trial. JAMA Dermatology, 154(1):37-43.
Niers LE, Timmerman HM, Rijkers GT, Bleek GM, Uden NP, Knol EF, Hoekstra MO. (2005). Identification of strong interleukin‐10 inducing lactic acid bacteria which down‐regulate T helper type 2 cytokines. Clinical & Experimental Allergy, 35(11):1481-1489.
Katoh N, Ohya Y, Ikeda M, Ebihara T, Katayama I, Saeki H, Shimojo N, Tanaka A, Nakahara T, Nagao M, Hide M, Fujita Y, Fujisawa T, Futamura M, Masuda K, Murota H, Yamamoto-Hanada K. (2019). Clinical practice guidelines for the management of atopic dermatitis 2018. Journal of Dermatology, 46(12):1053-1101.
Ong PY, Leung DY. (2006). Immune dysregulation in atopic dermatitis. Current Allergy and Asthma Reports, 6(5):384-389.
Oranje AP. (2011). Practical issues on interpretation of scoring atopic dermatitis: SCORAD index, objective SCORAD, patient-oriented SCORAD and three-item severity score. Current Problems in Dermatology, 41:149-155. 
Özdemir Ö. (2010). Various effects of different probiotic strains in allergic disorders: An update from laboratory and clinical data. Clinical and Experimental Immunology, 160(3): 295-304.
Peng GC, Hsu CH. (2005). The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite. Pediatr Allergy Immunol, 16:433-8.
Sartor RB. (2005). Probiotic therapy of intestinal inflammation and infections. Current Opinion in Gastroenterology, 21(1):44-50.
Savilahti E, Kuitunen M, Vaarala O. (2008). Pre and probiotics in the prevention and treatment of food allergy. Current Opinion in Allergy and Clinical Immunology, 8(3):243-248.
Shida K, Suzuki T, Kiyoshima-Shibata J, Shimada S, Nanno M. (2006). Essential roles of monocytes in stimulating human peripheral blood mononuclear cells with Lactobacillus casei to produce cytokines and augment natural killer cell activity. Clinical and Vaccine Immunology, 13:997-1003.
Shida K, Takahashi R, Iwadate E. (2002). Lactobacillus casei strain Shirota suppresses serum immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model. Clinical and Experimental Allergy, 32:563-70.
Sidbury R, Khorsand K. (2017) Evolving Concepts in Atopic Dermatitis. Current Allergy Asthma Reports, 17(7):42.
Simpson MR, Dotterud CK, Storrø O, Johnsen R, Øien T. (2015). Perinatal probiotic supplementation in the prevention of allergy related disease: 6 year follow up
of a randomised controlled trial. BMC Dermatolog, 15:13.
Tollefson MM, Bruckner AL. (2014). Atopic dermatitis: sking-directed management. American Academy of Pediatrics, 134(6):1735-44.
Tsai TF. (2018). Use of immunotherapy in non-neoplastic skin diseases. Formosan Journal of Medicin, 22(4):394- 404.
Umetsu DT, DeKruyff RH. (2006). The regulation of allergy and asthma. Immunological Reviews, 212(1): 238-255.
Vajihe A, Fatemeh H. (2016). Effects of probiotic supplementation in patients with type 2 diabetes: systematic review and meta-analysis. Nutrition Reviews, 74(12): 774–784.
Vliagoftis H, Kouranos VD, Betsi GI, Falagas ME. (2008). Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials. Ann Allergy Asthma Immunol, 101:570-9.
Wahlgren CF. (1991). Itch and atopic dermatitis: clinical and experimental studies. Acta Derm Venereol Suppl, 165:1-53.
Weidinger S, Novak N. (2016). Atopic dermatitis. The Lancet, 387:1109-1122.
Williams NT. (2010). Probiotics. American Journal of Health-System Pharmacy, 67(6): 449-458.
Williams H, Stewart A, Mutius E, Cookson W, Anderson HR. (2008). Is eczema really on the increase worldwide? The Journal of Allergy and Clinical Immunology, 121:947-954.
Yan F, Polk DB. (2011). Probiotics and immune health. Current Opinion in Gastroenterology, 27(6):496-501.
Yadav H, Jain S, Sinha PR. (2006). Effect of skim milk and dahi (yogurt) on blood glucose, insulin, and lipid profile in rats fed with high fructose diet. Journal of Medicinal Food, 9(3):328-335.
Zhang N, Liao X, Zhang Y, Li M, Wang W, Zhai S. (2019). Probiotic supplements for relieving stress in healthy participants: A protocol for systematic review and meta-analysis of randomized controlled trials. Medicine, 98(20):15416.

三、網站資料：
全國法規資料庫：https://law.moj.gov.tw/LawClass/LawAll.aspx?pcode=L0040012
行政院主計處：https://www.dgbas.gov.tw/

四、其它參考資料：
DUPIXENT solution for injection 300mg仿單, 衛部菌疫輸字第001082號